Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, GR 45110, Ioannina, Greece.
Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, GR 45110, Ioannina, Greece.
Adv Exp Med Biol. 2018;1067:353-371. doi: 10.1007/5584_2017_99.
In the last decade, the uptake of information and communication technologies and the advent of mobile internet resulted in improved connectivity and penetrated different fields of application. In particular, the adoption of the mobile devices is expected to reform the provision and delivery of healthcare, overcoming geographical, temporal, and other organizational limitations. mHealth solutions are able to provide meaningful clinical information allowing effective and efficient management of chronic diseases, such as heart failure. A variety of data can be collected, such as lifestyle, sensor/biosensor, and health-related information. The analysis of these data empowers patients and the involved ecosystem actors, improves the healthcare delivery, and facilitates the transformation of existing health services. The aim of this study is to provide an overview of (i) the current practice in the management of heart failure, (ii) the available mHealth solutions, either in the form of the commercial applications, research projects, or related studies, and (iii) the several challenges related to the patient and healthcare professionals' acceptance, the payer and provider perspective, and the regulatory constraints.
在过去的十年中，信息和通信技术的普及以及移动互联网的出现改善了连接性，并渗透到了不同的应用领域。特别是，移动设备的采用有望改革医疗保健的提供和交付方式，克服地理、时间和其他组织上的限制。移动医疗解决方案能够提供有意义的临床信息，从而有效地管理慢性病，如心力衰竭。可以收集各种数据，如生活方式、传感器/生物传感器和与健康相关的信息。对这些数据的分析使患者和相关生态系统参与者能够获得更多的力量，改善医疗服务的提供，并促进现有卫生服务的转变。本研究旨在概述：(i) 心力衰竭管理的当前实践；(ii) 现有的移动医疗解决方案，无论是商业应用、研究项目还是相关研究；以及 (iii) 与患者和医疗保健专业人员的接受程度、支付方和提供方的角度以及监管限制相关的几个挑战。
